Simply Solventless Files Its Q2 Numbers, but the Debt Plan Already Set the Stock's Price

On September 1, Simply Solventless Concentrates (TSXV: HASH; U.S. OTC: SSLCF) filed the unaudited financial statements for its quarter ended June 30, 2026— the quarterly numbers that fell overdue at the end of August. The release read like the checklist a distressed-stock holder wants to tick: filings caught up, the management cease-trade order's revocation expected within days, the private placement and debt settlement extended once more to a September 30 closing. None of that, though, is what makes the stock worth thinking about. The price of HASH stopped being set by earnings some time in 2026. It is being set by a court-approved restructuring that tells you, in its own currency, what the people inside the company believe the equity is worth. That price is C$0.05 per unit — and each unit comes with a free two-year warrant. The market's price for a bare share is about C$0.06. When the open market charges more for a share alone than informed money pays for a share with an option attached, the "discount" on the chart is not a discount at all.

A management cease-trade order needs translating for a U.S. reader, because it sounds worse than it acts. It is Canada's penalty for late filings, and it binds only the people inside the company: directors, officers and other insiders cannot trade their shares until the accounts are cured. Outside investors were never blocked from trading. The order was issued in May because the 2025 audited statements came due in the middle of a creditor-protection case and were not filed until late August; the Q1 2026 statements followed on August 31 and the Q2 statements on September 1. The company said the Q1 filing eliminated the last default and that revocation was expected about two business days later.

To see what those filings actually describe, start with where the company was a year ago. Simply Solventless is a Calgary manufacturer of solvent-free cannabis concentrates that grew by acquisition — buying the Massive Hash Factory, CannMart and ANC, then the Humble Grow cultivation business, and shipping brands such as Astrolab and Frootyhooty. In the quarter ended March 2025 it reported record net revenue of C$9.9 million; the following quarter, record gross revenue of C$13.0 million. The shares peaked at C$0.38 at the end of August 2025. Then the momentum broke: gross revenue fell 31% sequentially in the September quarter when one-time wholesale sales to newly opened provinces did not repeat, and net revenue has now come in around C$5.0–5.3 million for three consecutive quarters — Q4 2025 through Q2 2026. The company calls that stabilized; the other word for it is half of what Q1 2025 produced. At about C$0.06 the stock sits 84% below that August peak, and the roughly 115 million shares listed add up to a market value of about C$7 million. There is no dividend on the record today, which removes the anchor an income investor would normally use; the only possible return here is price recovery.

The collapse was a balance-sheet event, and the filings document it precisely. The acquisition roll-up was financed with 11% secured convertible debentures — originally convertible at C$1.00 — and 10–15% promissory notes, inside a tax structure where federal excise duties claimed roughly 20% of gross sales. The tipping point sits in the court record: as of February 23, 2026, the Canada Revenue Agency was owed about C$10.7 million in excise, payroll and sales-tax arrears across the three main subsidiaries, and the CRA had said it would visit the facilities to "reconcile and dispose of" cannabis inventory and excise stamps. On February 27, 2026, Simply Solventless and its subsidiaries were granted protection under the Companies' Creditors Arrangement Act — Canada's rough equivalent of U.S. Chapter 11.

The restructuring that followed, approved by the Court of King's Bench of Alberta and targeted to close by September 30, sets the prices that matter. New money can buy up to 20 million units at C$0.05 each — one share plus one warrant exercisable at C$0.10 for two years — a deal worth up to C$1.0 million, of which about C$0.5 million had been subscribed by late August, including roughly C$0.2 million from insiders. The same C$0.05 price applies to promissory notes of about C$1.6 million being converted into roughly 31.3 million units, and the note payments that remain drop by about two-thirds. The secured debentures, with about C$5.975 million outstanding, were amended so that up to C$3.0 million of principal converts into units at C$0.05 — C$2.2 million of elections were already in — and anything left converts under a price cut from C$1.00 to C$0.15, with warrants repriced from C$1.20 to C$0.25. Unsecured creditors are being discharged of roughly C$15 million. Total debt reduction is about C$20 million, with C$7.1 million a year of operating and debt-servicing costs expected to come out. The Massive Hash Factory has been shut, CannMart is being sold, and four facilities have become two: Humble Grow for cultivation and ANC for manufacturing. Management has said the acquisition model is over.

Do the arithmetic on the equity and you get the article's real number. Roughly 115 million shares are outstanding today; if all the conversions and the placement are taken, up to about 110 million new units can be issued — near enough to a doubling of the count — each dragging a C$0.10 warrant with it. Now line up the prices the restructuring has stamped on the equity: C$0.05 for a share plus a free warrant, C$0.06 for a bare share in the market, C$0.15 where secured lenders agreed to convert debt they once protected at C$1.00. The stock has already climbed about 50% off its March low of C$0.04. A claim that trades above the price its own principals and lenders pay, on top of a bounce off the low, is a re-rated speculation — cheap only against a price chart that no longer describes the capital structure.

Strip out the plan and the operating case rests on a single swing factor. On the gross-revenue run rate the company cites of C$2.8–3.1 million a month, against a break-even of about C$2.6 million a month, the cushion is a few hundred thousand dollars — thin enough that one bad quarter of excise or a slide in wholesale pricing removes it. The number that could change the outcome is the Humble retrofit: high-efficiency LED lighting and crop controls installed in 239 of 269 rooms, which management says has raised flower yields 75–80% since June at roughly the same cash cost, taking production from an 8–9 metric-tonne annual run rate toward a 14–20 metric-tonne target under new genetics. If it delivers, incremental cash flow of C$0.3–0.4 million a month would more than double the current cushion, and the roughly C$1.5 million retrofit cost is mostly offset by Manitoba rebates. The evidence boundary matters here as much as the number: those yields trace to initial, unaudited harvests of a couple of retained cultivars, the Phase 2 genetics are not yet planted, and the company itself says the cash-flow benefit shows up in the year-end numbers, not the next quarter. The upside is volume, and volume is only worth what Canadian cannabis prices still pay for it.

So the tests that settle whether this stock works are not the ones in the headlines. Watch whether the plan actually closes by September 30; whether the Q3 2026 statements — the first to reflect the slimmer cost base — show positive operating cash flow at the roughly C$5 million quarterly revenue level; whether that revenue holds instead of sliding again; and whether the final share count lands where the plan's terms imply. Add to that one governance item this same management has now earned twice in just over a year: a management cease-trade order ran from May to late June 2025 before the Q1 2025 statements were filed, and the current one has run since May 2026. Chronic late filing goes to the reliability of the information a value investor has to work from, and it deserves full weight in a company whose entire story is now debt-servicing relief sold in advance.

Until the winter numbers clear those gates, C$0.06 is a claim, not a value. The disciplined position is to watch from outside a capital structure that is still being renegotiated — and not to mistake a 50% rebound off the bottom for a floor the restructuring never actually set.